Leaderboards/Lymphatic Disorders and Treatments

Lymphatic Disorders and Treatments

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Enyuan Cao
Monash Institute of Medical Research
2
Malvika Bhatnagar
Oxford Health NHS Foundation Trust
3
Haiqin Zhong
Shanghai Children's Hospital
4
Madeline J. Churchill
Oregon Health & Science University
5
Chinmayee Sethy
Indian Institute of Technology Delhi
6
Laure Garnier
University Hospitals Geneva Medical Center
7
Suhag Patel
Seoul National University Hospital
8
Alicia B. Byrne
Broad Institute
9
Wanshu Ma
Northwestern University
10
Valentina Raglianti
European Society for Sexual Medicine

Rising Stars Papers

1
Chylothorax: pathophysiology, diagnosis, and management—a comprehensive review
Journal of Thoracic Disease|2024
95 cit.
2
Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants
Kidney International|2024
61 cit.
3
Anti-slit Antibodies against Podocin and Kirrel1 in Pediatric and Adult Podocytopathies
Journal of the American Society of Nephrology|2025
37 cit.
4
Enteric tuft cell inflammasome activation drives NKp46+ILC3 IL22 via PGD2 and inhibits <i>Salmonella</i>
The Journal of Experimental Medicine|2025
9 cit.
5
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications
Nephrology Dialysis Transplantation|2025
7 cit.
6
Effect of Macrolide Resistance and Mycoplasma pneumoniae DNA Load in Bronchoalveolar Lavage Fluid on Immune and Inflammatory Responses in Children with Mycoplasma pneumoniae Pneumonia
Indian Pediatrics|2025
4 cit.
7
Regulation of autoimmune‐mediated neuroinflammation by endothelial cells
European Journal of Immunology|2024
2 cit.
8
Anti-slit Antibodies on Kidney Biopsy Identify Patients with Steroid-Resistant Nephrotic Syndrome Responsive to Second-Line Immunosuppressant and Hence Have a Good Prognosis
Journal of the American Society of Nephrology|2024
1 cit.
9
Anti-podocin Enzyme-Linked Immunosorbent Assay Guides Immunotherapy in Steroid-Resistant Nephrotic Syndrome
Kidney International Reports|2025
1 cit.
10
P534: Piloting an Australian quality assurance program interpretive module for genomic testing
Genetics in Medicine Open|2024
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Jarosław Suchański
Wrocław University of Environmental and Life Sciences
2
Benjamin Pippard
Newcastle upon Tyne Hospitals NHS Foundation Trust
3
Michael T. Dellinger
The University of Texas Southwestern Medical Center
4
Saebeom Hur
Seoul National University
5
Ernesto Santos
University of Pittsburgh Medical Center
6
Michael Jeltsch
University of Helsinki
7
Qi Cheng
China Medical University
8
Beth A. Jirón Tamburini
University of Colorado Denver
9
Lin Yuan
Children’s Hospital of Fudan University Xiamen Branch
10
Sarah E. Sheppard
Children's Hospital of Philadelphia

Emerging Leaders Papers

1
Chylothorax: pathophysiology, diagnosis, and management—a comprehensive review
Journal of Thoracic Disease|2024
95 cit.
2
Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model
European Journal of Pediatrics|2023
68 cit.
3
Clinical characteristics of plastic bronchitis in children: a retrospective analysis of 43 cases
Respiratory Research|2022
59 cit.
4
Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition
JCI Insight|2023
36 cit.
5
Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomaly
European Journal of Human Genetics|2022
31 cit.
6
Central conducting lymphatic anomaly: from bench to bedside
Journal of Clinical Investigation|2024
21 cit.
7
Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice
Science Advances|2023
18 cit.
8
Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function
Frontiers in Cell and Developmental Biology|2023
18 cit.
9
Multiple overlapping microwave ablation in benign thyroid nodule: a single-center 24-month study
European Thyroid Journal|2022
17 cit.
10
Expansion and collapse of VEGF diversity in major clades of the animal kingdom
Angiogenesis|2023
16 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Michael Detmar
Harvard University
2
Maxim Itkin
Hospital of the University of Pennsylvania
3
Yukinari Kato
Tohoku University
4
Jay H. Ryu
Mayo Clinic
5
Donald M. McDonald
UCSF Helen Diller Family Comprehensive Cancer Center
6
Bryan Rodgers
Australian National University
7
Isao Koshima
Hiroshima University Hospital
8
Yoav Dori
Institute of Cardiology
9
Atsushi Miyajima
Meiji Pharmaceutical University
10
Mika K. Kaneko
Tohoku University

Current Senior Leaders Papers

1
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Nature Medicine|2001
1.7k cit.
2
Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness
American Journal Of Pathology|2000
1.7k cit.
3
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Science|1999
1.4k cit.
4
Inferior epigastric artery skin flaps without rectus abdominis muscle
British Journal of Plastic Surgery|1989
1.2k cit.
5
Functionally specialized junctions between endothelial cells of lymphatic vessels
The Journal of Experimental Medicine|2007
988 cit.
6
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
American Journal Of Pathology|2002
975 cit.
7
A short form of the Positive and Negative Affect Schedule: evaluation of factorial validity and invariance across demographic variables in a community sample
Personality and Individual Differences|1999
849 cit.
8
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Journal of Clinical Investigation|2006
798 cit.
9
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
American Journal of Physiology-Heart and Circulatory Physiology|2005
768 cit.
10
Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts
American Journal Of Pathology|2004
763 cit.

Reagents for Lymphatic Disorders and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

R&D Systems

Human Prox1 Antibody

#AF2727 (also AF2727-SP)
View Evidence →
Cell Signaling Technology

Phospho-eNOS (Ser113) Antibody

#9575$362
View Evidence →
Cell Signaling TechnologyEvidence 65

Myosin IIc Antibody

#3405$136,317
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

D2-40

Cited in 5 papers
#M3619
View Evidence →
AbcamEvidence 60

LYVE1 antibody - Lymphatic Vessel Marker

#ab14917
View Evidence →
Cell Signaling Technology

Phospho-EphA2 (Tyr588) (D7X2L) Rabbit Monoclonal Antibody

#12677$178,412
View Evidence →